<DOC>
	<DOCNO>NCT00538018</DOCNO>
	<brief_summary>Demonstrate efficacy telithromycin single-agent oral antibiotic usually prescribe local guideline ( `` usual care '' ) treat adult outpatient mild moderate community-acquired pneumonia ( CAP ) high bacterial resistance area .</brief_summary>
	<brief_title>Telithromycin , Treating Adult Outpatients With Mild Moderate Community-acquired Pneumonia ( CAP ) High Bacterial Resistance Areas</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Adult outpatient mild moderate CAP . Diagnosis CAP base presence fever and/or hyperleucocytosis new sudden onset least two clinical sign symptom pneumonia ( cough , dyspnea tachypnea , chill , pleuritic chest pain , purulent sputum change sputum character , auscultatory finding ) . Clinical diagnosis CAP confirm chest Xray finding ( e.g . presence presumably new infiltrate ) . Specimens microbiological documentation collect within 24 hour prior enrollment . Subjects require parenteral antibiotic treatment . Subjects severe CAP require hospitalization . The CAP consider severe presence follow condition : chest Xray show multilobar consolidation ( &gt; 1 lobe ) 3 and/ increase size opacity great = 50 % within 48 hour current evaluation shock alter mental status ( disorientation person , place time know chronic , lethargy , stupor coma ) total peripheral white blood cell count &lt; 4,000/mm3 requirement mechanical ventilation requirement vasopressor acute renal failure The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>